Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of PIKA Rabies Vaccine Consistency and Safety
NCT05667974Phase 3Active, not recruiting
- Sponsor
- LakeShore Biopharma Co., Ltd
- Start
- Sep 2023
- Primary completion
- Mar 2024
- Modality
- Adjuvant Therapy
- Countries
- 2
01
Overview
A Phase 3 trial of PIKA in rabies, sponsored by LakeShore Biopharma Co., Ltd. Started Sep 2023; status: active, not recruiting.
02
Drugs
PIKA
03
Conditions
rabies
Beyond the preview
Go deeper on NCT05667974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05667974.